Development of early malignant bilateral breast disease in relation to antidepressant treatment.
The aim of this study is to present two rare cases of young female patients who were under antidepressant medication and developed bilateral breast disease; histology confirmed the noninvasive, malignant nature. The role of that type of agents in the breast pathology is briefly discussed, based on the data of the current literature.
Markopoulos
C
C
Breast Unit-2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece.
Kouskos
E
E
Phillipidis
T
T
D000328:Adult; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000139:chemically induced*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000139:chemically induced*; D003511:Cyclohexanols / Q000009:adverse effects; D004727:Endothelium / Q000473:pathology*; D005260:Female; D018226:Fibroadenoma / Q000139:chemically induced*; D005473:Fluoxetine / Q000009:adverse effects; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D005473:Fluoxetine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride